Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-21 Sale | 2022-11-22 4:46 pm | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Director | 150,000 | $7.18 | $1,077,000 | 229,543 (Direct) | View |
| 2022-02-24 Sale | 2022-02-25 4:54 pm | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 10,812 | $8.74 | $94,497 | 325,162 (Direct) | View |
| 2022-01-03 Sale | 2022-01-04 9:30 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 4,500 | $64.71 | $291,192 | 85,500 (Direct) | View |
| 2021-09-01 Sale | 2021-09-07 4:05 pm | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 11,220 | $20.68 | $232,030 | 414,620 (Indirect Direct) | View |
| 2021-06-02 Sale | 2021-06-04 4:06 pm | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 23,000 | $17.33 | $398,590 | 225,104 (Direct) | View |
| 2021-01-04 Sale | 2021-01-05 6:14 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 4,000 | $76.09 | $304,360 | 90,000 (Direct) | View |
| 2020-09-14 Sale | 2020-09-16 7:15 pm | Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 47,861 | $27.19 | $1,301,253 | 425,087 (Direct) | View |
| 2020-09-10 Sale | 2020-09-11 7:59 pm | Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 27,128 | $26.08 | $707,581 | 554,444 (Direct) | View |
| 2020-05-12 Sale | 2020-05-13 6:48 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 36,000 | $35.83 | $1,289,891 | 8,000 (Direct) | View |
| 2019-09-09 Sale | 2019-09-11 8:09 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 185,000 | $29.41 | $5,440,000 | 36,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-15 Option Award | 2023-12-19 3:55 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 14,987 | $25.41 | 114,754 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:32 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 12,460 | $0 | 104,360 (Direct) | View |
| 2022-11-21 Exercise | 2022-11-22 4:46 pm | 2020-09-09 2022-11-27 | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Director | 150,000 | $0 | 229,543 (Direct) | View |
| 2022-11-21 Exercise | 2022-11-22 4:46 pm | N/A N/A | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Director | 150,000 | $5.99 | 229,543 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:15 pm | 2022-09-01 2031-12-22 | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 6,430 | $0 | 307,883 (Direct) | View |
| 2022-06-01 Other | 2022-06-02 5:01 pm | N/A N/A | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 23,754 | $0 | 321,712 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:54 pm | 2022-02-23 2031-12-22 | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 33,163 | $0 | 325,162 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 8:12 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 6,400 | $0 | 91,900 (Direct) | View |
| 2021-12-22 Option Award | 2021-12-27 4:30 pm | N/A 2031-12-22 | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 89,020 | $0 | 344,211 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-07 4:05 pm | N/A N/A | AVITA Medical Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 23,754 | $0 | 414,620 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-05 6:14 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 9,000 | $0 | 90,000 (Direct) | View |
| 2020-09-14 Option Award | 2020-09-16 7:15 pm | N/A N/A | Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 68,504 | $0 | 425,087 (Direct) | View |
| 2020-09-09 Option Award | 2020-09-11 7:59 pm | 2020-09-09 2028-11-30 | Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 108,333 | $0 | 554,444 (Direct) | View |
Ownership | 2020-07-10 4:27 pm | N/A N/A | Avita Therapeutics Inc. | RCEL | PERRY MICHAEL S Chief Executive Officer | 0 | $0 | 473,239 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-18 6:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 15,000 | $5.19 | 335,000 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-18 6:27 pm | 2014-09-21 2023-09-21 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 77,000 | $0 | 335,000 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-18 6:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 5,000 | $2.01 | 335,000 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-18 6:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 15,000 | $2.19 | 335,000 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-18 6:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 7,000 | $4.75 | 335,000 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-18 6:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 25,000 | $4.2 | 335,000 (Direct) | View |
| 2020-05-14 Exercise | 2020-05-18 6:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 10,000 | $2.62 | 335,000 (Direct) | View |
| 2019-05-09 Ownership | 2020-02-14 5:58 pm | 2016-11-22 2021-11-22 | Armata Pharmaceuticals Inc. | ARMP | PERRY MICHAEL S Director | 46,666 | $12,065 | 0 (Indirect) | View |
| 2020-01-01 Option Award | 2020-01-03 6:08 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 8,000 | $0 | 44,000 (Direct) | View |
| 2019-05-22 Option Award | 2019-05-24 9:30 pm | N/A 2029-05-22 | Armata Pharmaceuticals Inc. | ARMP | PERRY MICHAEL S Director | 27,383 | $0 | 27,383 (Direct) | View |